drugset / Trial / NCT00862888

Study to Investigate Effect of a New Drug (PF-00446687) in Males Suffering From Erectile Dysfunction

NCT00862888

Phase 2 Completed 39 enrolled Pfizer
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to investigate the effect of up to 200 mg of PF-00446687 on erectile activity in males suffering from erectile dysfunction as well as examining the safety and toleration of the drug.

Timeline

Start
2007-07
Primary completion
2008-02
Completion
2008-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator PF-00446687 Small molecule 20 mg Oral
Comparator PF-00446687 Small molecule 125 mg Oral
Comparator PF-00446687 Small molecule 175 mg Oral
Comparator PF-00446687 Small molecule 200 mg Oral
Comparator Sildenafil Unknown 100 mg Oral

Indications